ASOP Global’s Board of Directors provides strategic direction for all activities and our Academic Advisory Panel provides guidance regarding academic and consumer research on issues related to online patient safety. Faegre Drinker Consulting also provides strategic leadership and policy consulting to ASOP Global.
Board of Directors and Academic Advisory Panel
Board of Directors
Leigh Verbois, Board Chair
Senior Director
U.S. Pharmacopeia
Former Director, OSDIR, FDA
Matt Strait, Board Treasurer
Advisor
Controlled Substance Strategies
Lori Mayall, Board Secretary
Senior Associate General Counsel, Intellectual Property
Gilead Sciences
Keith Jacobs, Director
Co-CEO
Geniant
Ilisa Bernstein, Director
President
Bernstein Rx Solutions
Ryan Williams, Director
Director, Card Brand Solutions
LegitScript
Dan Burke, Director
Director of Intelligence & Investigations
U.S. Anti-Doping Agency
Former Division Chief, OCI, FDA
Elizabeth Jungman, Director
Partner, Hogan Lovells
Former Senior Policy Adviser, Office of the Commissioner
Jeff Gren, Director
President & Founder
Gren International Health and Trade Consulting
Carrie Harney, Director
Executive Director, Public Policy
Boehringer Ingelheim
John Hertig, Director
Founder
Hertig Healthcare Advising
Susan Wilson, Director
Consultant
WilsonIPR
Academic Advisory Panel
Timothy K. Mackey
Director, Global Health Policy Institute
University of California, San Diego School of Medicine
Dorothy L. Smith, PharmD
President and CEO
Consumer Health Information Corporation